Emtricitabine /tenofovir alafenamide

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

HIV-1 infection

Manufacturer:

Gilead Sciences Canada, Inc.

Call for patient/clinician input open:

January 4, 2016

Brand Name:

Descovy

Project Line:

Reimbursement Review

Project Number:

SR0470-000

Call for patient/clinician input closed:

February 23, 2016

NOC Status at Filing:

Pre NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

HIV-1 infection

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

August 24, 2016

Last Updated : October 9, 2018